BPC-157 / TB-500 Blend: A Tracking Guide for Pre-Mixed Recovery Stacks

BPC-157 and TB-500 are two of the most commonly stacked research peptides in recovery protocols. Some suppliers sell them pre-mixed in a single vial. The convenience is obvious; the cost is that you give up the ability to tune each peptide independently. Neither compound is approved for human use, and most of the underlying data is preclinical.

What the blend is supposed to do

The rationale for stacking is that the two peptides have overlapping but distinct profiles. BPC-157 is most discussed for gut, tendon, and ligament repair. TB-500 (a synthetic fragment associated with thymosin beta-4) is most discussed for actin regulation, cell migration, and broader soft-tissue and vascular effects. The combined claim is faster, more complete recovery from soft-tissue injury, with no good human trials behind it.

Why a pre-blend, and why not

• For: one injection instead of two, simpler dosing, sometimes cheaper per cycle
• Against: you cannot raise BPC-157 frequency without also raising TB-500, you cannot drop one if you suspect a side effect, and you are trusting the supplier's ratio and reconstitution math

If you are using peptides primarily for a single defined injury, separate vials are usually the more honest setup. A blend makes more sense for general recovery cycles where you have already decided on a fixed ratio.

Typical protocol shape

• Route: subcutaneous, sometimes local to an injured area
• Frequency: daily during a loading phase, often tapering to a few times per week
• Duration: 4–8 week cycles are common, followed by a break
• Ratio: blends commonly run 5 mg BPC-157 to 5 mg TB-500 per vial, but ratios vary

Because the ratio is fixed, your "dose" is really a single number — the volume drawn per injection — applied to both peptides at once.

What to track daily

• Pain rating in the target area (0–10)
• Range of motion or functional test specific to the injury
• Sleep quality
• Injection site reactions
• Any unexpected symptoms

What to track weekly

• Standardized movement test (e.g., pain-free squat depth, overhead reach, grip strength)
• Training load tolerated
• Recovery time between sessions
• Subjective overall recovery rating (1–10)

Realistic expectations

Self-reports on the blend cluster around faster perceived recovery from soft-tissue strains and tendinopathy-like complaints, with significant individual variation. The honest framing is: animal data is encouraging, human data is essentially anecdotal, and a placebo response in a motivated self-experimenter is large. Tracking pre-injury baseline performance is what makes the comparison meaningful.

Common mistakes

• Starting the blend, changing training, and adding physical therapy in the same week
• Using a blend when you actually want to test one peptide
• Skipping movement tests because the area "feels better"
• Running back-to-back cycles without a washout, which makes long-term tolerability hard to assess

A tracking template

• Week 0: baseline pain score, movement tests, photos of any visible injury, training log
• Weeks 1–4: daily injections, daily symptom log in Peptide IA
• Week 4: repeat movement tests; decide whether to extend or taper
• Weeks 5–8: optional extension at reduced frequency
• Weeks 9–12: washout; track whether symptoms return

Bottom line

A BPC-157 / TB-500 blend trades flexibility for convenience. It is a reasonable choice if you have already decided on a fixed-ratio recovery stack and want fewer injections. If you are still figuring out which peptide is doing what for you, separate vials and one-variable-at-a-time tracking will tell you more.

Peptide IA is an educational and self-tracking tool. Nothing in this post is medical advice. Doses mentioned reflect what is commonly reported in research literature — they are not recommendations. Always consult a qualified physician before starting, changing, or stopping any protocol.